CIK 0001645113
- Large accelerated filer
NovoCure Ltd
Sign in to watch- Ticker
- NVCR
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Entity type
- Operating
- Phone
- +44 1534756700
- Business address
- NO. 4 THE FORUM, GRENVILLE STREET, ST. HELIER, Jersey
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $142,786
- in 3 filings
Net −$142,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-13 | DOYLE WILLIAM F Executive Chairman | Sale | −600 | $216.69 | $130K | 555,393 |
| 2021-04-13 | Danziger Asaf Chief Executive Officer | Sale | −97,973 | $196.34 | $19.2M | 8,184 |
| 2021-04-13 | LEUNG GABRIEL Director | Exercise or conversion | +6,000 | $31.45 | $189K | 78,045 |
| 2021-04-13 | LEUNG GABRIEL Director | Sale | −3,500 | $198.01 | $693K | 74,545 |
| 2021-04-13 | LEUNG GABRIEL Director | Sale | −2,500 | $200.00 | $500K | 72,045 |
| 2021-04-13 | LEUNG GABRIEL Director | Exercise or conversion · Options to Buy Ordinary Shares | −6,000 | 6,345 | ||
| 2021-04-13 | Benaim Ely Chief Medical Officer | Exercise or conversion | +1,833 | $47.56 | $87K | 35,092 |
| 2021-04-13 | Benaim Ely Chief Medical Officer | Sale | −1,833 | $200.00 | $367K | 33,259 |
| 2021-04-13 | Benaim Ely Chief Medical Officer | Exercise or conversion | +651 | $83.30 | $54K | 33,910 |
| 2021-04-13 | Benaim Ely Chief Medical Officer | Sale | −651 | $200.00 | $130K | 33,259 |
| 2021-04-13 | Benaim Ely Chief Medical Officer | Exercise or conversion | +3,474 | $69.37 | $241K | 36,733 |
| 2021-04-13 | Benaim Ely Chief Medical Officer | Sale | −3,474 | $200.00 | $695K | 33,259 |
| 2021-04-13 | Benaim Ely Chief Medical Officer | Exercise or conversion · Options to Buy Ordinary Shares | −1,833 | 10,998 | ||
| 2021-04-13 | Benaim Ely Chief Medical Officer | Exercise or conversion · Options to Buy Ordinary Shares | −651 | 3,904 | ||
| 2021-04-13 | Benaim Ely Chief Medical Officer | Exercise or conversion · Options to Buy Ordinary Shares | −3,474 | 19,404 | ||
| 2021-04-01 | DOYLE WILLIAM F Executive Chairman | Sale | −7,928 | $134.12 | $1.1M | 650,393 |
| 2021-03-31 | DOYLE WILLIAM F Executive Chairman | Exercise or conversion | +9,259 | $125.25 | $1.2M | 658,321 |
| 2021-03-31 | DOYLE WILLIAM F Executive Chairman | Exercise or conversion · Restricted Stock Units | −9,259 | 0 | ||
| 2021-03-23 | Weinberg Uri Chief Science Officer | Sale | −2,835 | $140.00 | $397K | 33,471 |
| 2021-03-23 | Weinberg Uri Chief Science Officer | Exercise or conversion | +3,892 | $47.04 | $183K | 40,198 |
Page 31 of 32 · 638 trades